Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer
We report a method of synthesis and optimization of amino-functionalized silica nanoparticles (SiNPs) and their in vitro evaluation as targeted delivery vehicles for the potential treatment of pancreatic cancer. SiNPs can efficiently encapsulate doxorubicin and can be attached to a targeting moiety...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Journal of Nanotechnology |
Online Access: | http://dx.doi.org/10.1155/2013/768724 |
id |
doaj-a00dc2ce084e4ede8415ed2008b338c9 |
---|---|
record_format |
Article |
spelling |
doaj-a00dc2ce084e4ede8415ed2008b338c92020-11-24T22:30:28ZengHindawi LimitedJournal of Nanotechnology1687-95031687-95112013-01-01201310.1155/2013/768724768724Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic CancerAbbey Y. Kardys0Dhruba J. Bharali1Shaker A. Mousa2Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY 12144, USAPharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY 12144, USAPharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY 12144, USAWe report a method of synthesis and optimization of amino-functionalized silica nanoparticles (SiNPs) and their in vitro evaluation as targeted delivery vehicles for the potential treatment of pancreatic cancer. SiNPs can efficiently encapsulate doxorubicin and can be attached to a targeting moiety such as anti-Claudin-4 (CLN4). The preferential uptake in pancreatic cancer cells, where CLN4 is overexpressed, of SiNPs when conjugated to CLN4 antibody (compared to nonconjugated SiNPs) was confirmed by confocal microscopy. SiNPs encapsulating doxorubicin had greater efficacy in MTT assays than free doxorubicin, and when conjugated to CLN4, the efficacy was dramatically increased (at 1 μM). No apparent carrier toxicity was observed when void SiNPs were used. SiNPs carrying a chemotherapeutic drug have the potential to be used as a targeted therapy for lethal cancers, such as pancreatic cancer. Also, incorporation of fluorescent probes in these SiNPs creates the possibility of their use as an imaging probe for diagnostic purposes.http://dx.doi.org/10.1155/2013/768724 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Abbey Y. Kardys Dhruba J. Bharali Shaker A. Mousa |
spellingShingle |
Abbey Y. Kardys Dhruba J. Bharali Shaker A. Mousa Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer Journal of Nanotechnology |
author_facet |
Abbey Y. Kardys Dhruba J. Bharali Shaker A. Mousa |
author_sort |
Abbey Y. Kardys |
title |
Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer |
title_short |
Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer |
title_full |
Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer |
title_fullStr |
Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer |
title_full_unstemmed |
Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer |
title_sort |
amino-functionalized silica nanoparticles: in vitro evaluation for targeted delivery and therapy of pancreatic cancer |
publisher |
Hindawi Limited |
series |
Journal of Nanotechnology |
issn |
1687-9503 1687-9511 |
publishDate |
2013-01-01 |
description |
We report a method of synthesis and optimization of amino-functionalized silica nanoparticles (SiNPs) and their in vitro evaluation as targeted delivery vehicles for the potential treatment of pancreatic cancer. SiNPs can efficiently encapsulate doxorubicin and can be attached to a targeting moiety such as anti-Claudin-4 (CLN4). The preferential uptake in pancreatic cancer cells, where CLN4 is overexpressed, of SiNPs when conjugated to CLN4 antibody (compared to nonconjugated SiNPs) was confirmed by confocal microscopy. SiNPs encapsulating doxorubicin had greater efficacy in MTT assays than free doxorubicin, and when conjugated to CLN4, the efficacy was dramatically increased (at 1 μM). No apparent carrier toxicity was observed when void SiNPs were used. SiNPs carrying a chemotherapeutic drug have the potential to be used as a targeted therapy for lethal cancers, such as pancreatic cancer. Also, incorporation of fluorescent probes in these SiNPs creates the possibility of their use as an imaging probe for diagnostic purposes. |
url |
http://dx.doi.org/10.1155/2013/768724 |
work_keys_str_mv |
AT abbeyykardys aminofunctionalizedsilicananoparticlesinvitroevaluationfortargeteddeliveryandtherapyofpancreaticcancer AT dhrubajbharali aminofunctionalizedsilicananoparticlesinvitroevaluationfortargeteddeliveryandtherapyofpancreaticcancer AT shakeramousa aminofunctionalizedsilicananoparticlesinvitroevaluationfortargeteddeliveryandtherapyofpancreaticcancer |
_version_ |
1725740809284747264 |